HLA-C and neoplasm: Being free of MHC restriction, younger NKT cells may be more feasible and reliable for addressing the viral or tumor mutants than other T cell subsets and relevant antibodies in that NKT recognizes them quickly and directly without sensitization, unlike B cells that have to be sensitized for a period of time to produce antibodies.